Ibrutinib increases the risk of hypertension and atrial fibrillation: Systematic review and meta-analysis.
Daniel CaldeiraDaniela AlvesJoão CostaJoaquim J FerreiraFausto J PintoPublished in: PloS one (2019)
Ibrutinib was associated with significantly increased risks of both hypertension and atrial fibrillation.
Keyphrases
- atrial fibrillation
- blood pressure
- oral anticoagulants
- catheter ablation
- left atrial
- chronic lymphocytic leukemia
- left atrial appendage
- direct oral anticoagulants
- heart failure
- percutaneous coronary intervention
- human health
- risk assessment
- mitral valve
- acute coronary syndrome
- venous thromboembolism
- climate change